くすりのしおり

Injection
Revised: 1/2018

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Edaravone for I.V.Infusion 30mg "Kyorin"
 Active ingredient:
Edaravone
 Dosage form:
Injection
 Print on wrapping:

Effects of this medicine

This medicine protects brain by scavenging free radicals which increase in region with a poor blood flow.
It is usually used to improve symptoms of cerebral infarction such as paralysis and numbness in limbs and performance impairment of daily living, or improve the condition to enable normal activities.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have renal dysfunction, infectious disease, hepatic dysfunction, cardiac disorder or conscious disorder.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, for adult, this medicine is given by intravenous drip infusion over 30 minutes twice a day.
  • The treatment span is determined according to your symptoms, however, within 14 days.

Precautions while taking this medicine

  • Receive blood tests frequently (the frequency depends on your symptoms) to check your renal/hepatic/blood function when injecting this medicine.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include fever, rash, redness, swelling, wheal, itch and erythema. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • decreased urine output, swelling, malaise [acute renal failure, nephrotic syndrome]
  • general malaise, loss of appetite, yellowing of the skin and the white of eyes [fulminant hepatitis, hepatic dysfunction, jaundice]
  • nose/gum bleeding, fever, sore throat [decreased platelets, decreased granulocytes]
  • bruise, nose/gum bleeding, palpitation or shortness of breath [disseminated intravascular coagulation syndrome]
  • fever, cough, respiratory distress [acute pulmonary disorder]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z